Medical Marijuana Inc (MJNA)

[Ecostate]

Medical Marijuana, Inc. Subsidiary Kannaway(R) Celebrates Best Revenue Month in Company History for South Africa and Japan Divisions in January 2022

9:00 am ET February 15, 2022 (Globe Newswire) Print
via NewMediaWire --Medical Marijuana, Inc. (OTC: MJNA) (the "Company"), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands, and supply chain, announced today that its subsidiary Kannaway(R) achieved its largest revenue month in the company's history in its Japan and South Africa divisions in January 2022.

According to Business Insider Africa, Africa's cannabis industry is projected to grow beyond a $7 billion valuation by 2023. Reach and Markets highlights that the Asia-Pacific market is also expected to grow exponentially with a CAGR of 28.6% from 2020 to 2027.

"Being able to achieve four best revenue months in a row in the Japan market has been both a great way to end 2021 and an inspiring way to start 2022," said Medical Marijuana, Inc. CEO Blake Schroeder. "Now that we've reached this milestone in South Africa as well, we anticipate that both regions will be major market areas for us this year and beyond."

To learn more about Kannaway(R), please visit the Company online at https://www.kannaway.com/.

About Kannaway(R)

Kannaway(R) is a network sales and marketing company specializing in the sales and marketing of hemp-based botanical products. Kannaway(R) currently hosts weekly online sales meetings and conferences across the United States, offering unique insight and opportunity to sales professionals who are desirous of becoming successful leaders in the sale and marketing of hemp-based botanical products.